About Optopol
Optopol is a Healthcare company based in Zawiercie (Poland) founded in 1992. It manufactures ophthalmic diagnostic tools including SD OCT and visual field analyzers for healthcare providers. It operates on a B2B model. Optopol offers products and services including REVO FC 130, REVO HR, PTS 2000, and REVO NX 130. Its focus areas include Medical Tech, Ophthalmic Diagnostics, Optical Coherence Tomography and Visual Field Analysis. Its legal entity is OPTOPOL TECHNOLOGY SP. Z O.O. Its competitors include NuvoAir, QuidelOrtho, BioSerenity, ProciseDx and Neurosynaptic and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
OPTOPOL Technology specializes in creating advanced diagnostic equipment for ophthalmology, such as spectral-domain OCT and fundus cameras. They innovate in perimetry and optical coherence tomography, offering modular systems with high scan speeds. Based in Zawiercie, Poland, with a subsidiary in Raleigh, USA, they serve global healthcare providers through distributors and direct sales, focusing on efficient and versatile eye care solutions.
- Headquarters Zawiercie, Poland
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website optopol.com
- Social LinkedIn Facebook Instagram
- Legal Name Optopol Technology Sp. Z O.O.
Products & Services of Optopol
Optopol offers a comprehensive portfolio of products and services, including REVO FC 130, REVO HR, PTS 2000, and REVO NX 130.
High-speed OCT system for detailed eye imaging and diagnostics.
Advanced camera for retinal imaging in ophthalmic examinations.
Automated device for assessing visual field defects accurately.
OCT device with enhanced features for ocular axial measurements.
Competitors of Optopol
Optopol has 9 listed competitors in our database, 8 of them funded. They include NuvoAir, QuidelOrtho, BioSerenity, ProciseDx and Neurosynaptic, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nuvoair.com | 2015 | Stockholm, Sweden | $28.1M | – | Clinical decision support tools for respiratory diseases are provided. | |
| quidelortho.com | 1937 | San Diego, United States | – | 278 | Provider of healthcare information services | |
| bioserenity.com | 2014 | Paris, France | $120.96M | – | Provider of smart healthcare solutions for sleep and EEG lab management | |
| procisedx.com | 2018 | San Diego, United States | $8.96M | – | Point-of-care diagnostic devices for immunoassay tests are provided to clinicians. | |
| neurosynaptic.com | 2002 | Bengaluru, India | $1.61M | 29 | ICT-based products and solutions are developed for healthcare. | |
| medtel.io | 2016 | Bengaluru, India | $996,158 | 23 | Remote patient monitoring software is developed for healthcare providers. | |
| wuxidiagnostics.com | 2018 | Rochester, United States | $200M | – | Diagnostic solutions for disease identification are offered to healthcare providers. | |
| coagulomed.com | 2018 | Newton, United States | $6.5M | – | Precision-medicine platform for blood coagulation disease diagnosis is offered. | |
| immuneiq.com | 2008 | Minneapolis, United States | $54.99M | – | A point-of-care platform for diagnosing immune diseases is provided. |
Detailed competitors of Optopol
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Optopol
Websites that share an audience with Optopol (optopol.com).
Websites whose visitors overlap most with Optopol. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ziemergroup.com | 99% | 4.6K | #3,659,331 | View details |
Top companies in Ophthalmology
10 companies that operate in the same segment as Optopol (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Optopol
Optopol was founded in 1992.
Optopol is headquartered in Zawiercie, Poland. It is registered at Zawiercie, Silesian Voivodeship, Poland.
OPTOPOL Technology specializes in creating advanced diagnostic equipment for ophthalmology, such as spectral-domain OCT and fundus cameras. They innovate in perimetry and optical coherence tomography, offering modular systems with high scan speeds. Based in Zawiercie, Poland, with a subsidiary in Raleigh, USA, they serve global healthcare providers through distributors and direct sales, focusing on efficient and versatile eye care solutions.
Optopol's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
Optopol offers REVO FC 130, REVO HR, PTS 2000, and REVO NX 130.
Optopol operates through Optopol Technology Sp. Z O.O..